The China Pulmonary Thromboembolism Registry Study

Launched by CHINA-JAPAN FRIENDSHIP HOSPITAL · Oct 21, 2016

Keywords

ClinConnect Summary

The China Pulmonary Thromboembolism Registry Study (CURES) is a research project aimed at understanding pulmonary embolism (PE) and deep venous thrombosis (DVT) in China. It began in 2009 and involves collecting data from patients who are suspected of having PE or confirmed cases of PE with DVT across 100 medical centers. The goal is to gather updated information on how these conditions affect patients in China, including their causes and how they progress over time. Patients aged 18 and older who are admitted to these hospitals with confirmed symptoms of PE or DVT may be eligible to participate.

If you join this study, you will be monitored during your hospital stay, and researchers will follow up with you for at least three months to see how you are doing. Additionally, starting in 2016, the study has included collecting blood samples from participants to help with long-term research. Your participation is voluntary, and all necessary ethical approvals have been obtained to ensure the study is conducted safely and respectfully.

Gender

ALL

Eligibility criteria

• • Patients aged 18 years or above who are admitted to the 100 participating medical centers with suspected PE or PE with DVT are potentially eligible participants and consecutively enrolled in this registry.
• Inclusion criteria:
• • Objectively confirmed symptomatic PE or PE with DVT patients aged 18 years or above;
• • Be able to provide written or verbal informed consent to participation.
• Exclusion criteria:
• • Younger than 18 years;
• • Participation in a therapeutic clinical trial with an unknown drug;
• • Inability for at least three-month follow-up since July 2011;
• • Suspected PE or PE with DVT patients admitted to the hospital whereas without confirmed medical evidence;
• • Patients with a history of PE or DVT readmitted to the hospital for examination or treatment however with no evidence of acute episode or recurrence;
• • Withdrawal or lack of informed consent.